Filter
804
Filtered Results: 804
Text search:
Pharmaceutical
Prices
Featured
Recommendations
68
New Publications
235
Language
Document type
No document type
409
Studies & Reports
189
Guidelines
106
Strategic & Response Plan
36
Manuals
25
Fact sheets
17
Situation Updates
9
Training Material
7
Resource Platforms
5
Brochures
1
Countries / Regions
Global
34
India
32
South Africa
22
Kenya
21
Ethiopia
20
Uganda
19
Ukraine
15
Sierra Leone
14
Nigeria
14
Nepal
14
Liberia
12
Ghana
11
Zimbabwe
11
Zambia
11
Tanzania
11
Bangladesh
11
Syria
10
Philippines
9
Western and Central Europe
9
Indonesia
8
Malawi
8
Namibia
8
Latin America and the Carribbean
8
Rwanda
7
Myanmar / Burma
7
Africa
7
Congo, Democratic Republic of
6
Senegal
5
Germany
5
Botswana
5
Eastern Europe
5
Cameroon
4
Cambodia
4
Benin
4
Venezuela
4
Burkina Faso
3
Haiti
3
Pakistan
3
Lebanon
3
Mozambique
3
Papua New Guinea
3
Eswatini/ Swaziland
3
Lesotho
3
South–East Asia Region
3
Asia
3
Albania
3
North America
3
South Sudan
2
Egypt
2
Sudan
2
Peru
2
Yemen
2
West and Central Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Laos
2
Jamaica
2
Guinea
1
Mali
1
Niger
1
Jordan
1
Afghanistan
1
Chad
1
Thailand
1
China
1
Central African Republic
1
North Macedonia
1
El Salvador
1
Libya
1
Sri Lanka
1
East and Southern Africa
1
Western Pacific Region
1
Paraguay
1
Fiji
1
Bhutan
1
Palestine
1
Mongolia
1
Southern Africa
1
Tajikistan
1
Russia
1
Bulgaria
1
Romania
1
Lithuania
1
Moldova
1
Kyrgyzstan
1
Vietnam
1
Gabon
1
Turkmenistan
1
Denmark
1
Authors & Publishers
Publication Years
Category
Countries
323
Clinical Guidelines
62
Public Health
43
Women & Child Health
20
Key Resources
17
Pharmacy & Technologies
16
Capacity Building
3
Toolboxes
Pharmacy
92
AMR
67
COVID-19
67
HIV
64
Mental Health
49
TB
25
NCDs
21
Global Health Education
20
Health Financing Toolbox
18
Conflict
16
Planetary Health
15
NTDs
11
Ebola
10
Caregiver
7
Rapid Response
6
Disability
5
Refugee
5
Polio
3
Natural Hazards
3
Specific Hazards
2
Cholera
1
South Sudan
1
Health Financing
1
This situation analysis has gathered information about the current state of AMR, contributing factors and antimicrobial use in Zimbabwe from the human, animal, agricultural and environmental sectors. Data has been gathered from different sectors such as the general public, academia, the Ministry of ...
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate...
The ECA, says over 300,000 Africans could lose their lives due to COVID-19. This, as the pandemic continues to impact on the Continent’s struggling economies whose growth is expected to slow down from 3.2 percent to 1.8 percent in a best-case scenario, pushing close to 27 million people into extr...
PERC produces regional and member state situation analyses, updated regularly.
Background paper 7
The Independent Panel for Pandemic Preparedness and Response
May 2021
Has the world worked together to tackle the coronavirus? July 2021. This research paper assesses how the global community has responded to calls for greater solidarity in tackling the COVID-19 pandemic, and presents the insights of key stakeholders and experts in global health governance, health sec...
The figures and findings reflected in the 2020 PMR represent the independent analysis of the United Nations (UN) and its humanitarian partners based on information available to them. Many of the figures provided throughout the document are estimates based on sometimes incomplete and partial data set...
This Study presents the key results of a research that analyses the implications of an ambitious agroecological transition across Europe, following the TYFA scenario. Published in 2018, what it proposes by 2050 is fully aligned with the objectives that the European Farm to Fork and Biodiversity stra...
The Kenyan Health Sector has been playing a critical role in
providing health care services in response to the population
needs in line with the Kenya Health Policy, 2014-2030’s goal
of attaining the highest possible health standards in a manner
responsive to the population needs.
A view of global supply chains, pressure points, and implications for antimicrobial resistance response
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k...
This fourth WHO report on neglected tropical diseases (NTDs) reviews the progress made towards achieving the Roadmap targets for 2020, noting the remaining challenges, then looks beyond 2020 to evaluate the changing global health and development landscape, considering the implications of integrating...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
